Holen Sie sich die Stockscreener-App
5.85
7.29%
-0.46
Handel nachbörslich:
5.86
0.01
+0.17%
Schlusskurs vom Vortag:
$6.31
Offen:
$6.35
24-Stunden-Volumen:
1.08M
Relative Volume:
0.79
Marktkapitalisierung:
$561.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-144.32M
KGV:
-2.6835
EPS:
-2.18
Netto-Cashflow:
$-105.21M
1W Leistung:
+2.45%
1M Leistung:
-16.43%
6M Leistung:
+38.63%
1J Leistung:
+37.65%
1-Tages-Spanne:
$5.83
$6.3799
1-Wochen-Bereich:
$5.72
$6.71
52-Wochen-Spanne:
$2.25
$8.20
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Firmenname
Compass Pathways Plc Adr
Sektor
Branche
Telefon
1-716-676-6461
Adresse
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, UHS, FMS, ENSG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
5.85 | 605.87M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
535.22 | 118.85B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
232.26 | 19.89B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
234.05 | 14.45B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.46 | 13.94B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
214.41 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-23 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-02-27 | Eingeleitet | Stifel | Buy |
| 2024-07-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2022-11-21 | Fortgesetzt | Berenberg | Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-10-29 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
| 2021-05-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-01 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-13 | Eingeleitet | Berenberg | Buy |
| 2020-10-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-13 | Eingeleitet | Cowen | Outperform |
| 2020-10-13 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Compass Pathways Plc Adr Aktie (CMPS) Neueste Nachrichten
COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure - FXEmpire
COMPASS Pathways plc's (NASDAQ:CMPS) institutional investors lost 16% over the past week but have profited from longer-term gains - Sahm
COMPASS Pathways (NASDAQ:CMPS) Stock Price Down 7.6%Should You Sell? - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Nuclear Stocks To Watch Today – January 22nd - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Expand Energy Corporation (NASDAQ:EXE) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Investors Buy Large Volume of COMPASS Pathways Call Options (NASDAQ:CMPS) - Defense World
COMPASS Pathways Target of Unusually High Options Trading (NASDAQ:CMPS) - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading Down 5.5%What's Next? - MarketBeat
Commonwealth Equity Services LLC Boosts Position in Fidelity Enhanced Emerging Markets ETF $FEMR - Defense World
CMPS: COMP360 is poised to transform TRD and PTSD care with rapid, durable efficacy and broad support - TradingView — Track All Markets
CMPS: COMP360 is set to transform psychiatric care for PTSD and TRD with rapid, durable outcomes - TradingView — Track All Markets
COMPASS Pathways (NASDAQ:CMPS) Sets New 1-Year HighShould You Buy? - MarketBeat
CMPS: COMP360 demonstrates rapid, durable efficacy in TRD and PTSD, supporting near-term commercialization - TradingView — Track All Markets
Compass Pathways stock rises after FDA accepts IND for PTSD treatment By Investing.com - Investing.com South Africa
Compass Pathways stock rises after FDA accepts IND for PTSD treatment - Investing.com
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with Radial Health - Kalkine Media
Compass Pathways forms seventh strategic collaboration with Radial Health By Investing.com - Investing.com India
Compass Pathways forms seventh strategic collaboration with Radial Health - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Simplify Asset Management Inc. Purchases Shares of 290,000 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution - Finviz
COMPASS Pathways (NASDAQ:CMPS) Trading 4.5% HigherStill a Buy? - MarketBeat
Analyzing COMPASS Pathways (NASDAQ:CMPS) & HealthEquity (NASDAQ:HQY) - Defense World
COMPASS Pathways (NASDAQ:CMPS) Reaches New 12-Month HighShould You Buy? - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Shares Gap UpWhat's Next? - MarketBeat
Healthy Upside Potential: Compass Pathways Plc ADR (CMPS) - setenews.com
Oppenheimer upgrades Compass Pathways stock to Outperform on FDA pathway By Investing.com - Investing.com UK
COMPASS Pathways PLC Sponsored ADR $CMPS Position Boosted by 22NW LP - MarketBeat
Schroder Investment Management Group Makes New $1.53 Million Investment in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
1,075,485 Shares in COMPASS Pathways PLC Sponsored ADR $CMPS Purchased by Hsbc Holdings PLC - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 10.7% HigherWhat's Next? - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Prepare Yourself for Liftoff: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Stock: Navigating Volatility in Psychedelic Medicine () - aktiencheck.de
Ready to Jump After Recent Trade: Triller Group Inc (ILLR) - Setenews
Investors in cash trouble should check out Compass Pathways Plc ADR (CMPS) - Setenews
Bridger Management LLC Purchases New Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Discontinued operations of COMPASS Pathways Plc Sponsored ADR – HAM:5Y6 - TradingView
COMPASS Pathways Plc Sponsored ADR Trade Ideas — HAM:5Y6 - TradingView
The time has not yet come to remove your chips from the table: Compass Pathways Plc ADR (CMPS) - Setenews
Free cash flow per share of COMPASS Pathways Plc Sponsored ADR – LS:A2QCDR - TradingView
This trade activity should not be overlooked: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Placera.se
Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - Barchart.com
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com
Finanzdaten der Compass Pathways Plc Adr-Aktie (CMPS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):